ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Gastrointestinal Autologous Reconstruction for Management of Chronic Gut Failure in the New Era of Visceral Transplantation

    K. M. Abu-Elmagd, S. R. Armanyous, N. R. Parekh, D. McMichael, M. Fujiki, K. Hashimoto, A. Khanna, A. Shatnawei, G. Costa.

    Center for Gut Rehabilitation & Transplantaion, Cleveland Clinic Foundation, Cleveland, OH.

    OBJECTIVE(S): Chronic gut failure(CGF) is associated with life-threatening complications, impaired life-quality, and burdened healthcare-cost. With recent advances in autologous-reconstruction along with visceral transplantation, evidence-based practical…
  • 2018 American Transplant Congress

    Prophylaxis of Wound Infections- Antibiotics in Renal Donation (POWAR): A Multicentre UK Double Blinded Placebo Controlled Randomised Controlled Trial

    Z. Ahmed, R. Uwechue, N. Kessaris, N. Mamode.

    Abdominal Transplant Unit, Guy's Hospital, London, United Kingdom.

    AIM: Postoperative infection following hand assisted laparoscopic donor nephrectomy (HALDN) confers significant morbidity. Previous reports suggest 1 in 5 patients develop infective complications. No modifiable…
  • 2018 American Transplant Congress

    DAP12 and Its Triggering Co-Receptor TREM2 Play Key Roles in Regulation of Mouse and Human Liver DC Function and Control of Liver Ischemia-Reperfusion Injury

    T. Nakao,1 Y. Ono,1 H. Dai,1 A. Perez-Gutierrez,1 G. Camirand,1 H. Huang,1 D. Geller,1,2 A. Thomson.1,3

    1Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA; 2Liver Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA; 3Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.

    Background: Liver interstitial dendritic cells (DCs) have been implicated in the control of liver ischemia/reperfusion injury (IRI) and in the induction of liver transplant tolerance.…
  • 2018 American Transplant Congress

    Predicting Survival after Deceased-Donor Kidney Transplants by Donor-Recipient Match: Who Can Tolerate a High-KDPI Kidney?

    S. Bae, J. Garonzik Wang, K. Jackson, A. Thomas, X. Luo, A. Massie, D. Segev.

    Johns Hopkins School of Medicine, Baltimore, MD.

    Deceased-donor kidney transplantation (DDKT) with high-KDPI kidneys carries an additional risk of mortality and graft failure, which could be tolerable for some candidates but detrimental…
  • 2018 American Transplant Congress

    Transplantation of Kidneys from Hepatitis C Virus (HCV) Antibody (Ab) Positive, NAT Negative Donors to HCV Negative Patients Results in Seroconversion but Not Viral Transmission

    M. de Vera, M. Volk, Z. Ncube, A. Kore, M. Robinson, P. Wai, S. Blais, P. Baron, R. Villicana.

    Transplant Surgery, Loma Linda University Health, Loma Linda, CA.

    Anecdotal reports have suggested that transplantation of HCV Ab+/NAT- donor kidneys into HCV negative recipients is safe and not associated with HCV transmission. With the…
  • 2018 American Transplant Congress

    Endothelin-1 Type A Receptor Antibodies Are Associated with Elevated Il-8, Arteritis and Decline in Renal Function in Pediatric Renal Transplant Recipients

    M. Pearl,1 J. Grotts,1 M. Rossetti,1 Q. Zhang,1 P. Weng,1 E. Reed,1 E. Tsai Chambers.2

    1University of California, Los Angeles, Los Angeles, CA; 2Duke University, Durham, NC.

    Background: We have recently shown that the non-HLA antibody, AT1R-Ab, is prevalent and associated with poor outcomes in pediatric kidney transplant recipients (KTRs). The prevalence…
  • 2018 American Transplant Congress

    Impact of Changes to the LAS Calculation

    R. Lehman,1 R. Carrico,1 K. Uccellini,1 K. Chan,2 T. Whelan.3

    1United Network for Organ Sharing, Richmond, VA; 2Univ of Michigan, Ann Arbor, MI; 3Medical Univ of South Carolina, Charleston, SC.

    Purpose: On 2/19/2015 major revisions to the Lung Allocation Score (LAS) calculation were made to more appropriately reflect candidates' waiting list urgency and post-transplant survival.…
  • 2018 American Transplant Congress

    Human Thrombomodulin Expression on Genetically Modified Donor Pigs is Required to Maintain the Anti-Coagulation Profile

    A. Singh, L. DiChiacchio, J. Chan, P. Corcoran, B. Lewis, M. Thomas, D. Ayares, K. Horvath, M. Mohiuddin.

    CSRP/NHLBI and DVR/ORS, NIH, Bethesda, MD; Revivicor Inc., Blacksburg, VA; Dept of Surgery, University of Maryland, Baltimore, MD.

    Introduction: Coagulation dysregulation is major limitation for xenotransplantation but it is resolved to some extent by making genetically engineered (GE) pigs, which express complement inhibitors…
  • 2018 American Transplant Congress

    Treatment Outcomes of Recurrent Primary Focal Segmental Glomerulosclerosis (FSGS) after Kidney Transplantation

    R. Aguiar,1 F. Pereira,2 A. Gasparini,3 P. Chowdhury,1 D. Game,1 D. Moutzouris.1

    1Department of Nephrology and Transplantation, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom; 2Department of Renal Medicine, Hospital Dr. Fernando Fonseca, Lisbon, Portugal; 3Department of Health Sciences, University of Leicester, Leicester, United Kingdom.

    Introduction: Primary FSGS can recur in the renal allograft and is associated with poor graft outcomes. There is no established therapeutic intervention to prevent or…
  • 2018 American Transplant Congress

    Precision Medicine for Determining the Efficacy of a Novel Belatacept Regimen

    J. Shoji, J. Leung, E. Tavares, Q. Tang, F. Vincenti.

    Transplant Nephrology, UCSF, San Francisco, CA.

    IntroBelatacept is increasingly used as maintenance immunosuppression to improve long term outcomes in kidney transplant. Since acute rejection in patients on belatacept have been noted…
  • « Previous Page
  • 1
  • …
  • 130
  • 131
  • 132
  • 133
  • 134
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences